āĻšā§āĻŽFAGR âĸ EBR
add
Fagron NV
ā§§ā§Ž.ā§Žā§ŽâŦ
ā§¨ā§Ž āĻāĻžāĻ¨ā§, ā§§:ā§Ēā§¨:ā§Ēā§ AM GMT +ā§§ · EUR · EBR · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§§ā§Ž.ā§Ģā§ĒâŦ
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§§ā§Ž.ā§Ģā§ĻâŦ - ā§§ā§Ž.ā§¯ā§ŽâŦ
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§§ā§Ģ.ā§§ā§ĒâŦ - ā§¨ā§Ļ.ā§Ļā§ĢâŦ
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§§ā§Šā§Š.ā§Žā§Ŧ āĻā§ EUR
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§ā§§.ā§Ļā§¯Â āĻšāĻž
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
ā§§ā§.ā§ā§Ģ
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
ā§§.ā§§ā§§%
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
EBR
āĻŦāĻžāĻāĻžāĻ° āĻ¸āĻāĻŦāĻžāĻĻ
Evrim AÄacÄą
ā§§ āĻāĻ¨ā§āĻāĻž āĻāĻā§
US Markets React To AI Pressures As Dow Gains Amid Turmoil
ā§§ā§Ŧ.ā§Žā§Ŧ%
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (EUR) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§¨ā§§.ā§Ēā§Â āĻā§ | ā§§ā§Ģ.ā§Ģā§Ģ% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§Ŧ.ā§Ēā§Ŧ āĻā§ | ā§§ā§.ā§¨ā§Ŧ% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§¨.ā§Ļā§¨Â āĻā§ | ā§¨ā§¨.ā§Šā§% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | ā§¯.ā§Ēā§¨ | ā§Ģ.ā§¯ā§Ŧ% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | â | â |
EBITDA | ā§Š.ā§ā§Â āĻā§ | ā§§ā§Ž.ā§Ēā§¨% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | ā§¨ā§§.ā§Šā§¯% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (EUR) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§¯.ā§Žā§ŠÂ āĻā§ | -ā§§ā§.ā§Ēā§Ē% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§§ā§Ļā§Ē.ā§Ģā§§Â āĻā§ | ā§§.ā§¯ā§¯% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Ģā§Ŧ.ā§ā§¯Â āĻā§ | -ā§¨.ā§ā§Ž% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Ēā§.ā§ā§§Â āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§.ā§Šā§Ļ āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§¨.ā§Žā§Ŧ | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§.ā§Ŧā§§% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | ā§¯.ā§Šā§Ģ% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (EUR) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§¨.ā§Ļā§¨Â āĻā§ | ā§¨ā§¨.ā§Šā§% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | ā§¨.ā§§ā§Ļ āĻā§ | -ā§Š.ā§§ā§§% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§¨.ā§§ā§ŽÂ āĻā§ | -ā§Ŧā§Ē.ā§Šā§% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§§.ā§Ŧā§¨Â āĻā§ | ā§Ļ.ā§Šā§% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | -ā§§.ā§Žā§¨Â āĻā§ | -ā§§ā§ā§Ŧ.ā§ā§Ŧ% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | ā§§.ā§Ģā§Ļ āĻā§ | ā§Šā§§.ā§Ģā§¯% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
Fagron NV is a publicly traded multinational group of companies governed by Belgian law. Its registered office is located in Waregem, Belgium, and its headquarters is located at Rotterdam, Netherlands. Founded as Arseus NV, it was formerly the Professional Health Division of Omega Pharma, and became an independent entity via an IPO on October 5, 2007 and has been listed on Euronext Brussels and Euronext Amsterdam since then. Its share is included in the BEL MID-index and the Amsterdam Small Cap Index. The head office of Fagron is located in Rotterdam. Wikipedia
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§§ā§¯ā§¯ā§Ļ
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§Š,ā§Ŧā§Ēā§
